Spectral imaging: bands, artifacts, landmarks
IEEE SIGPORT · 08.10.2026
DOI: 10.60864/takr-ad93 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE SIGPORT, erschienen am 08.10.2026.
Abstract (Originalsprache)
Background
Surgical spectral imaging can show tissue properties the eye cannot, but the wavelength physics, the artifacts and the clinical evidence are rarely read together. This review sets them side by side.
Methods
Narrative review of public sources; the search was not systematic. Evidence is tagged by level (established, human in vivo, human specimens, animal or phantom, prototype, registered only) and each row names its source. Parts of the text were drafted with AI assistance and were reviewed, edited and approved by the author.
Results
Haemoglobin has a Soret band near 420 to 430 nm, oxyhaemoglobin peaks at 542 and 576 nm, isosbestic points allow referencing, and oxygenation contrast is strong near 660 nm. Lipid and water absorption extends into the short-wave infrared. ICG is excited near 805 nm and emits near 835 nm. ICG readouts lack cross-vendor calibration, and autofluorescence can give false positives. Label-free imaging is limited by glare, referencing, motion, and blood and smoke. Human evidence is mostly perfusion; tissue identification rests mostly on specimen and animal work.
Conclusions
Evidence is strongest for perfusion. Tissue discrimination is at an early stage. The remaining gaps reflect evidence yet to be generated and mark open research white space.
Schlagwörter
Zitieren
APA
(2026). Spectral imaging: bands, artifacts, landmarks. IEEE SIGPORT. https://doi.org/10.60864/takr-ad93
Vancouver
Spectral imaging: bands, artifacts, landmarks. IEEE SIGPORT. 2026. doi:10.60864/takr-ad93
BibTeX
@article{euvimed2026,
title = {Spectral imaging: bands, artifacts, landmarks},
journal = {IEEE SIGPORT},
year = {2026},
doi = {10.60864/takr-ad93}
}
EUVIMED